DSHEA implementation hearing
This article was originally published in The Tan Sheet
House Government Reform Committee oversight hearing tentatively scheduled for March 25 at 10 a.m. Committee Chair Dan Burton (R-Ind.) will address FDA's proposed rule on structure/function claims, the agency's new "disease claim" definition and possibly the recent federal appeals court decision regarding FDA's "significant scientific agreement" standard and health claims in supplement labeling ("The Tan Sheet" Jan. 25, p. 3). Commissioner Jane Henney, MD, is the invited FDA rep. Citizens for Health's Susan Haeger also is slated to testify
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC